WASHINGTON (dpa-AFX) - Quest Diagnostics (DGX) and PathAI, a global provider
of artificial intelligence-powered technology for pathology, announced
collaboration to accelerate the adoption of digital and AI pathology innovations
to improve efficiency in diagnosing cancer and other diseases. Quest will
acquire select assets of PathAI Diagnostics, the business of PathAI that
provides anatomic and digital pathology laboratory services.

Also, Quest will license PathAI's AISight digital pathology image management
system to support its pathology laboratories and customer sites in the United
States. Quest will be a preferred provider for PathAI's biopharmaceutical
clinical laboratory services.

For More Such Health News, visit rttnews.com.



Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX